AI-Generated ‘Minister’ Makes Historic Address To Albania’s Parliament
Is the future of politics already here? In Albania, it just might be. On Thursday, the world’s first AI government minister — a digital entity
Is the future of politics already here? In Albania, it just might be. On Thursday, the world’s first AI government minister — a digital entity
Imagine a government minister who never takes a bribe, never oversleeps, and doesn’t even exist in the flesh. That’s exactly what Albanian Prime Minister Edi
For more than 200 years, doctors have relied on the humble stethoscope to listen to the heart. But what if that familiar tool could do
What happens when the tool designed to help ends up doing harm? That’s the heartbreaking question at the center of a new lawsuit against OpenAI.
Robots sprinting, tumbling, and even crashing into each other—welcome to Beijing’s World Humanoid Robot Games. Kicking off on Friday, the three-day spectacle brings together 280
Could artificial intelligence be the hero in our fight against superbugs? Researchers at MIT think so. They’ve just unveiled two brand-new antibiotic candidates — designed
What if robots could navigate the world using brain-like power—while barely sipping energy? That’s exactly what Australian researchers have just achieved. Meet LENS—Locational Encoding with
How frustrated is Mark Zuckerberg with Meta’s AI game? Frustrated enough to throw billions at it—specifically, at Scale AI and its ambitious CEO Alexandr Wang.
While most of the world was still asleep Thursday, Chinese AI startup DeepSeek quietly dropped an upgrade to its R1 model—R1-0528. It was released on
Elon Musk just pulled off another headline-grabbing deal—this time, selling his own social media platform, X, to his AI company, xAI, for a cool $45
Imagine asking a chatbot for information about yourself—only to find out it claims you murdered your own children. That’s exactly what happened to a Norwegian
Liver cancer is one of the deadliest cancers worldwide, and even after surgery, the battle isn’t over—up to 70% of patients face a relapse. But
